Details for New Drug Application (NDA): 084629
✉ Email this page to a colleague
NDA 084629 describes HYDROXOMIN, which is a drug marketed by Bel Mar and is included in one NDA. Additional details are available on the HYDROXOMIN profile page.
The generic ingredient in HYDROXOMIN is hydroxocobalamin. There are four drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the hydroxocobalamin profile page.
The generic ingredient in HYDROXOMIN is hydroxocobalamin. There are four drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the hydroxocobalamin profile page.
Summary for 084629
| Tradename: | HYDROXOMIN |
| Applicant: | Bel Mar |
| Ingredient: | hydroxocobalamin |
| Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 084629
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | INJECTABLE;INJECTION | Strength | 1MG/ML | ||||
| Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
